Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

RAAJ MEDISAFE INDIA LTD.

NSE : NABSE : 524502ISIN CODE : INE548H01015Industry : Medical Equipment/Supplies/AccessoriesHouse : Private

BSE83.343.96 (+4.99 %)

PREV CLOSE ( ) 79.38

OPEN PRICE ( ) 83.30

BID PRICE (QTY) 80.80 (100)

OFFER PRICE (QTY) 83.34 (200)

VOLUME 400

TODAY'S LOW / HIGH ( )83.30 83.34

52 WK LOW / HIGH ( ) 58122.6

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1985

Management Info

Arpit Bangur - Chairman Arpit Bangur - Managing Director

Registered Office

Address 75/2 And 3,Industrial Area,Maksi Road,
Ujjain,
Madhya Pradesh-456010

Phone 0734-2518989 / 2513349

Email raajmedisafe@gmail.com

Website www.raajmedisafeindia.com

Registrars Details

Ankit Consultancy Pvt Ltd

Plot No 60,Electronic Complex,Pardeshipura,Indore

Listing : BSE

NEWS

09Dec Raaj Medisafe India informs about loss
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of In..

07Dec Raaj Medisafe India informs about loss
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of In..

15Apr Raaj Medisafe India informs about comp
Raaj Medisafe India has informed that it enclosed Compliance Certificate..

24Jan Raaj Medisafe India informs about loss
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of In..

16Jan Raaj Medisafe India informs about capa
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Re..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	10.25	33.2799999999999
Gross Profit	12.84	42.8799999999999
Operating Profit	22.04	66.9099999999999
Net Sales	145.9	432.49

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Laxmi Denta (BSE) 391.00 (5.83%)	M.Cap ( in Cr)2149.02
Prevest Denpro (BSE) 481.00 (1.92%)	M.Cap ( in Cr)577.34
Hemant Surgical Inds (BSE) 102.50 (5.13%)	M.Cap ( in Cr)107.01
Nureca Ltd. (BSE) 247.60 (2.00%)	M.Cap ( in Cr)247.60
GKB Ophthalmics (BSE) 68.75 (5.56%)	M.Cap ( in Cr)34.65

Shareholding Pattern

	PROMOTERS	73.44%
	NON-INSTITUTION	26.56%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

RAAJ MEDISAFE INDIA LTD.